19 Results for "

VPAC2

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "VPAC2" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-P0176
CAS No.: 127317-03-7
Synonyms: PACAP 1-27
Target:  

PACAP Receptor

PACAP (1-27), human, ovine, rat (PACAP 1-27) is the N-terminal fragment of PACAP-38, and is a potent PACAP receptor agonist with IC50s of 3 nM, 2 nM and 5 nM for rat PAC1, rat VPAC1 and human VPAC2, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0176A
Synonyms: PACAP 1-27 TFA
Target:  

PACAP Receptor

PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is the N-terminal fragment of PACAP-38, and is a potent PACAP receptor agonist with IC50s of 3 nM, 2 nM and 5 nM for rat PAC1, rat VPAC1 and human VPAC2, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-133529
CAS No.: 878437-15-1
Purity:  97.00%
PA-8 is a potent, selective and orally active PACAP type I (PAC1) receptor antagonist. PA-8 inhibits the phosphorylation of CREB induced by PACAP in PAC1-, but not VPAC1- or VPAC2-receptor. PA-8 also inhibits PACAP-induced cAMP elevation with an IC50 of 2 nM [2].
loading...
    loading...
Cat. No.: HY-P1160
CAS No.: 463930-25-8
Target:  

GCGR

Research Areas:  

Metabolic Disease

Bay 55-9837 is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 may be a useful therapy for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P11288
CAS No.: 2871680-36-1
Research Areas:  

Cancer

ANT308 is a vasoactive intestinal polypeptide (VIP receptor) antagonist. ANT308 significantly enhances the activation and proliferation of T cells. ANT308 inhibits the migration and metastasis, induces apoptosis of melanoma tumor cells by inhibiting VIP-VPAC2 signaling and reducing the expression of MCAM and N-cadherin. ANT308 can be used for the studies of acute myeloid leukemia (AML) and uveal melanoma (UVM) [2].
loading...
    loading...
Cat. No.: HY-P11288A
Research Areas:  

Cancer

ANT308 TFA is a vasoactive intestinal polypeptide (VIP receptor) antagonist. ANT308 TFA significantly enhances the activation and proliferation of T cells. ANT308 TFA inhibits the migration and metastasis, induces apoptosis of melanoma tumor cells by inhibiting VIP-VPAC2 signaling and reducing the expression of MCAM and N-cadherin. ANT308 TFA can be used for the study of acute myeloid leukemia (AML) and uveal melanoma (UVM) [2].
loading...
    loading...
Cat. No.: HY-P5111
CAS No.: 2243219-86-3
Target:  

Peptides

Research Areas:  

Neurological Disease

Myristoyl-(Lys12,27,28)-VIP-Gly-Gly-Thr (free acid) is a high-affinity and selective VPAC2 receptor antagonist .
loading...
    loading...
Cat. No.: HY-P4776
CAS No.: 202463-00-1
Target:  

PACAP Receptor

Research Areas:  

Metabolic Disease

Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), a vasoactive intestinal peptide (VIP), is a VIP1 antagonist .
loading...
    loading...
Cat. No.: HY-P10768A
Target:  

PACAP Receptor

Research Areas:  

Inflammation/Immunology

Ro 25-1553 TFA is a 31 amino acid vasoactive intestinal peptide (VIP) analog, that acts as an agonist for VIP2 receptor (VPAC2 receptor). Ro 25-1553 TFA exhibits a bronchodilator effect in nerve-induced or Carbachol (HY-B1208)-induced tracheal smooth muscle contraction in guinea pig model .
loading...
    loading...
Cat. No.: HY-P10768
CAS No.: 159427-08-4
Target:  

PACAP Receptor

Research Areas:  

Inflammation/Immunology

Ro 25-1553 is a selective VIP2 receptor (VPAC2 receptor) agonist. Ro 25-1553 exhibits bronchodilatory effects on tracheal smooth muscle contractions induced by nerve stimulation or Carbachol (HY-B1208). Ro 25-1553 produces a superimposed effect when combined with Formoterol and Salmeterol (HY-14302). Ro 25-1553 can be used for the study of bronchoconstriction .
loading...
    loading...
Cat. No.: HY-P1160A
Target:  

GCGR

Research Areas:  

Metabolic Disease

Bay 55-9837 TFA is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 TFA may be a useful therapy for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P1817
CAS No.: 144025-82-1
Target:  

PACAP Receptor

Research Areas:  

Cardiovascular Disease

PACAP-38 (16-38), human, mouse, rat is a peptide fragment encompassing the C-terminal 16-38 segment of PACAP (1-38), human, ovine, rat (HY-P0221). PACAP-38 (16-38), human, mouse, rat lacks the N-terminal 1-15 receptor activation core, but retains the ability to bind to the PAC/VPAC receptor family (PAC1/VPAC1/VPAC2 receptor). PACAP-38 (16-38), human, mouse, rat promotes histamine release and exerts a certain degree of hypotensive effect [2].
loading...
    loading...
Cat. No.: HY-P81526
Synonyms: VIP2R; VIPR2; Vasoactive intestinal polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary adenylate cyclase-activating polypeptide type III receptor (PACAP type III receptor; PACAP-R-3; PACAP-R3); VPAC2

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P81526A
Synonyms: VIP2R; VIPR2; Vasoactive intestinal polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary adenylate cyclase-activating polypeptide type III receptor (PACAP type III receptor; PACAP-R-3; PACAP-R3); VPAC2

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P76128
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Vasoactive intestinal polypeptide receptor 2; VIP-R-2; PACAP-R3; VPAC2; VIPR2
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P10768B
Target:  

PACAP Receptor

Research Areas:  

Inflammation/Immunology

Ro 25-1553 acetate is a selective VIP2 receptor (VPAC2 receptor) agonist. Ro 25-1553 acetate exhibits bronchodilatory effects on tracheal smooth muscle contractions induced by nerve stimulation or Carbachol (HY-B1208). Ro 25-1553 acetate produces a superimposed effect when combined with Formoterol and Salmeterol (HY-14302). Ro 25-1553 acetate can be used for the study of bronchoconstriction .
loading...
    loading...
Cat. No.: HY-RS18849
Research Areas:  

Others

Vipr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vipr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P1817A
Target:  

PACAP Receptor

Research Areas:  

Cardiovascular Disease

PACAP-38 (16-38), human, mouse, rat acetate is a peptide fragment encompassing the C-terminal 16-38 segment of PACAP (1-38), human, ovine, rat (HY-P0221). PACAP-38 (16-38), human, mouse, rat acetate lacks the N-terminal 1-15 receptor activation core, but retains the ability to bind to the PAC/VPAC receptor family (PAC1/VPAC1/VPAC2 receptor). PACAP-38 (16-38), human, mouse, rat acetate promotes histamine release and exerts a certain degree of hypotensive effect [2].
loading...
    loading...
Cat. No.: HY-RS15656
Research Areas:  

Others

VIPR2 Human Pre-designed siRNA Set A contains three designed siRNAs for VIPR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
  • 1